WINDTREE THERAPEUTICS INC /DE/ Amortization
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Amortization of $3.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2021-05-13
- WINDTREE THERAPEUTICS INC /DE/ amortization for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ amortization for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ amortization for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ amortization for the quarter ending 2020-03-31 was $3.00K, a 94.55% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ amortization for fiscal 2020 was $3.00K, a 98.16% decline from fiscal 2019.
- WINDTREE THERAPEUTICS INC /DE/ amortization for fiscal 2019 was $163.00K, a 81.11% decline from fiscal 2018.
- WINDTREE THERAPEUTICS INC /DE/ amortization for fiscal 2018 was $863.00K.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month | Amortization 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $0.00 derived: sum of 2 quarters · filed 2021-03-29 | $0.00 derived: sum of 3 quarters · filed 2021-03-29 | $3.00K 10-K · filed 2021-03-29 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $3.00K 10-Q · filed 2020-11-16 | $39.00K derived: sum of 4 quarters · filed 2021-05-13 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $3.00K 10-Q · filed 2020-08-14 | $39.00K derived: sum of 3 quarters · filed 2021-05-13 | $74.00K derived: sum of 4 quarters · filed 2021-05-13 |
| 2020-03-31 | $3.00K 10-Q · filed 2021-05-13 | $39.00K derived: sum of 2 quarters · filed 2021-05-13 | $74.00K derived: sum of 3 quarters · filed 2021-05-13 | $111.00K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $71.00K derived: sum of 2 quarters · filed 2021-03-29 | $108.00K derived: sum of 3 quarters · filed 2021-03-29 | $163.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $72.00K derived: sum of 2 quarters · filed 2020-11-16 | $127.00K 10-Q · filed 2020-11-16 | $687.00K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $92.00K 10-Q · filed 2020-08-14 | $652.00K derived: sum of 3 quarters · filed 2020-08-14 | |
| 2019-03-31 | $55.00K 10-Q · filed 2020-05-13 | $615.00K derived: sum of 2 quarters · filed 2020-05-13 | ||
| 2018-12-31 | $560.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | $863.00K 10-K · filed 2020-04-03 | ||
| 2018-09-30 | $303.00K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |